The Biological Macromolecule Shared Resource (BMSR) represents a consolidation of services previously offered by the Molecular Biology and the Virus Vector shared resources, with the addition of a new service for recombinant protein production and purification. The overall goal of the BMSR is to facilitate and implement multiple end-points, both those within this shared resource, and those involving interfacing with other shared resources. These include the production of research grade virus particles, knock-in/knock-out mice (in collaboration with the Transgenic/Knockout Mouse Shared Resource), knock-in/knock-out somatic cell lines using homologous recombination, transient and stable protein expression in mammalian cells, recombinant protein production (bacterial, yeast, insect, and mammalian systems) and purification for structural analysis (in collaboration with the Structural Biology Shared Resource), and for protein interaction studies using the Biacore instrumentation located in the Flow Cytometry shared resource. In addition to moving vectors provided by investigators towards these end points, we offer design, construction and validation services for the generation of new vectors. The BMSR is co-directed by Dr Shirley Taylor (CMG), who brings molecular biology, cell culture, and protein expression experience, and Dr Darrell Peterson (Department of Biochemistry and Molecular Biology) a protein biochemist with extensive experience in protein production and purification. The BMSR employs a Resource Manager (Ms Kimberly Stratton, MS) and two full time research specialists, each of whom takes primary responsibility for one of the three major areas, but with sufficient cross-training in ail services offered to ensure continuity and maximal efficiency. The BMSR generally operates at >85% capacity, serving a wide range of investigators both within the Virginia Commonwealth University (VCU) Massey Cancer Center (MCC), and from the VCU research community. For the period January 1 2008 through December 31, 2010, MCC members with peer-reviewed funding accounted for approximately 70% of basic services and special projects. In CY 2010 the virus vector services of the BMSR served five funded MCC investigators, and three non-MCC investigators. Since its inception in January 2010, the Protein Production facility has served five funded MCC investigators and two non-MCC investigators, on ten separate projects. The BMSR served 22 peer-reviewed funded MCC investigators in routine services and special projects and 15 non-MCC investigators.
The Biological Macromolecule Shared Resource assists MCC investigators in creating both DNA and protein molecules which in turn are used to study the molecular nature of cancer. Molecular manipulation provides the tools by which individual genes and proteins can be studied at the cellular and organismal levels. The production of purified protein allows investigators to determine the structure of cancer-related molecules, which in turn lends itself to understanding how the proteins can be manipulated to control cancer.
|Ginder, Gordon D (2015) Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res 165:115-25|
|Chen, Shuang; Zhang, Yu; Zhou, Liang et al. (2014) A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. Blood 124:2687-97|
|Youniss, Fatma M; Sundaresan, Gobalakrishnan; Graham, Laura J et al. (2014) Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling. PLoS One 9:e109162|
|Teves, Maria E; Sears, Patrick R; Li, Wei et al. (2014) Sperm-associated antigen 6 (SPAG6) deficiency and defects in ciliogenesis and cilia function: polarity, density, and beat. PLoS One 9:e107271|
|Bie, Jinghua; Wang, Jing; Yuan, Quan et al. (2014) Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice. J Lipid Res 55:729-38|
|Teramachi, Jumpei; Zhou, Hua; Subler, Mark A et al. (2014) Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J Bone Miner Res 29:1456-65|
|Nakagawa, Akito; Lui, Francine E; Wassaf, Dina et al. (2014) Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling. ACS Chem Biol 9:2318-25|
|Sarkar, S; Azab, B; Quinn, B A et al. (2014) Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus. Curr Mol Med 14:125-40|
|Dhall, Sandeep; Do, Danh; Garcia, Monika et al. (2014) A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity. PLoS One 9:e109848|
|Rahmani, Mohamed; Aust, Mandy Mayo; Benson, Elisa C et al. (2014) PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo. Clin Cancer Res 20:4849-60|
Showing the most recent 10 out of 215 publications